DENISE SCHLEEPER: Open Payments
NPI 1144642539 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 18 payments from 11 companies in 2025. Trend: 2023 $1,614 · 2024 $1,078 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Abbott Laboratories | 3 | $74 |
| Medtronic, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Corcept Therapeutics | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Radius Health, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
Products named: FREESTYLE LIBRE 3, Ozempic, MINIMED 780G, JARDIANCE, Korlym, TZIELD, LEQVIO, EVENITY.
Industry payments across MO — which companies pay providers there.
